Otsuka Hits Indian Pharma Co. With IP Suit Over Kidney Drug
Otsuka Pharmaceutical Co. has sued Indian drug manufacturer Lupin for patent infringement over a planned generic version of Otsuka's kidney treatment drug Jynarque, which is used to treat patients suffering from...To view the full article, register now.
Already a subscriber? Click here to view full article